News & Press Releases
Grand Opening of Hauenstein Center Features Visensia’s Early Warning System for Patient Safety
Grand Rapids, Michigan - Feb. 19, 2009 - Saint Mary’s Health Care, a member organization of Trinity Health, has completed its new Hauenstein Center facility and celebrated with several Grand Opening events, including a Community Open House on Sunday, February 15. The Hauenstein Center is a comprehensive neuroscience center with a new Emergency and Trauma Center and two floors of private critical care inpatient rooms. In this state-of-the-art facility, Saint Mary’s staff selected OBS Medical’s Visensia® patient safety suite to support its patient care operations. Together, the Hauenstein Center staff and OBS Medical are pioneering a breakthrough innovation benefiting patients and clinicians alike.
Frost & Sullivan recognized OBS Medical with the 2008 North American Frost & Sullivan Technology Innovation Award for its cutting edge Visensia® hospital patient safety suite. Visensia’s automated early warning technology fuses up to five vital signs – heart rate, respiration rate, body temperature, oxygen saturation and blood pressure – into a predictive, numerical index. The Visensia Index is an indication of a patient’s wellness and can enable significant improvement in clinical outcomes and optimization of hospital resource utilization. When the Index reaches and/or surpasses the default threshold, a Visensia Alert is triggered.
Visensia technology has been used as a tool to improve patient care and safety at Saint Mary’s since 2006. This innovative and proactive approach to patient care will be used with each of the 32 beds in the Hauenstein Center critical care unit. “We expect our critical care unit to still be state-of-the-art twenty years from now. Visensia will help us ‘red flag’ patients at risk for deterioration, so we can intervene earlier and prevent crises,” comments Clinical Nurse Specialist Lisbeth Votruba, RN.
“We are thrilled that Saint Mary’s has found continued value in Visensia and will be using it in the Hauenstein Center. They understand that in today’s challenging healthcare environment, hospitals must maximize patient safety and optimize clinical resources. The Visensia technology may be used as a resource management tool to ensure the optimal level of care is given to those who need it most,” says Frank Cheng, President and CEO of OBS Medical.
About OBS Medical
OBS Medical is based in Carmel, Indiana and provides innovative clinical algorithms for safer hospitals, safer patients and safer drugs. Based on intelligent algorithms such as neural networks, data fusion and ECG waveform recognition, OBS Medical technologies cover a range of medical applications including automated early crisis warning (Visensia®), automated assessment of ECG waveforms including QT interval measurement and morphology tracking (BioQT™), and EEG analysis for brain-state assessment. OBS Medical is a wholly-owned subsidiary of Oxford BioSignals Ltd. based in Oxford, UK, which was originally spun out from Oxford University.
Contact:
OBS Medical
Meredith Formsma
1-866-424-6744
meredith.formsma@obsmedical.com
http://www.obsmedical.com
